139 related articles for article (PubMed ID: 18403653)
1. The obesity epidemic: pharmacological challenges.
Bloom SR; Kuhajda FP; Laher I; Pi-Sunyer X; Ronnett GV; Tan TM; Weigle DS
Mol Interv; 2008 Apr; 8(2):82-98. PubMed ID: 18403653
[TBL] [Abstract][Full Text] [Related]
2. Emerging pharmacological approaches to the treatment of obesity.
Wasan KM; Looije NA
J Pharm Pharm Sci; 2005 Aug; 8(2):259-71. PubMed ID: 16124937
[TBL] [Abstract][Full Text] [Related]
3. Evolutionary origins of obesity.
Bellisari A
Obes Rev; 2008 Mar; 9(2):165-80. PubMed ID: 18257754
[TBL] [Abstract][Full Text] [Related]
4. Energy balance, physical activity, and cancer risk.
Fair AM; Montgomery K
Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
[TBL] [Abstract][Full Text] [Related]
5. Another type of intervention: treating obesity with medication.
Greenway F
J Am Diet Assoc; 2005 Jun; 105(6):895-8. PubMed ID: 15942538
[No Abstract] [Full Text] [Related]
6. Pharmacological and surgical treatments for obesity.
DeWald T; Khaodhiar L; Donahue MP; Blackburn G
Am Heart J; 2006 Mar; 151(3):604-24. PubMed ID: 16504622
[No Abstract] [Full Text] [Related]
7. What is the prognosis for new centrally-acting anti-obesity drugs?
Heal DJ; Gosden J; Smith SL
Neuropharmacology; 2012 Jul; 63(1):132-46. PubMed ID: 22313529
[TBL] [Abstract][Full Text] [Related]
8. [Xenical--a modern perspective drug for the treatment of obesity (review)].
Mkrtumian AM; Biriukova EV
Ter Arkh; 2007; 79(10):35-9. PubMed ID: 18154143
[No Abstract] [Full Text] [Related]
9. Thrifty genes for obesity, an attractive but flawed idea, and an alternative perspective: the 'drifty gene' hypothesis.
Speakman JR
Int J Obes (Lond); 2008 Nov; 32(11):1611-7. PubMed ID: 18852699
[TBL] [Abstract][Full Text] [Related]
10. Cultural perceptions of healthy weight in rural Appalachian youth.
Williams KJ; Taylor CA; Wolf KN; Lawson RF; Crespo R
Rural Remote Health; 2008; 8(2):932. PubMed ID: 18503293
[TBL] [Abstract][Full Text] [Related]
11. Challenges in the discovery and development of new agents for the treatment of obesity.
Staten MA
Clin Pharmacol Ther; 2007 May; 81(5):753-5. PubMed ID: 17377527
[TBL] [Abstract][Full Text] [Related]
12. FGF21: a novel prospect for the treatment of metabolic diseases.
Kharitonenkov A; Shanafelt AB
Curr Opin Investig Drugs; 2009 Apr; 10(4):359-64. PubMed ID: 19337957
[TBL] [Abstract][Full Text] [Related]
13. Medical interventions in adolescent obesity.
Khan UI; Collier M
Adolesc Med State Art Rev; 2008 Dec; 19(3):406-20, viii. PubMed ID: 19227383
[TBL] [Abstract][Full Text] [Related]
14. Novel pharmacotherapies for obesity poised to enter market.
Jones D
Nat Rev Drug Discov; 2009 Nov; 8(11):833-4. PubMed ID: 19876031
[No Abstract] [Full Text] [Related]
15. Anti-obesity effects of small molecule melanin-concentrating hormone receptor 1 (MCHR1) antagonists.
Luthin DR
Life Sci; 2007 Jul; 81(6):423-40. PubMed ID: 17655875
[TBL] [Abstract][Full Text] [Related]
16. A nonadaptive scenario explaining the genetic predisposition to obesity: the "predation release" hypothesis.
Speakman JR
Cell Metab; 2007 Jul; 6(1):5-12. PubMed ID: 17618852
[TBL] [Abstract][Full Text] [Related]
17. Opportunities and challenges for the development of pharmacological therapies for obesity treatment.
Cawthorne MA
Obes Rev; 2007 Mar; 8 Suppl 1():131-6. PubMed ID: 17316316
[No Abstract] [Full Text] [Related]
18. [Pharmacological sheet. Orlistat, oral administration (Xenical, Alli). ].
J Pharm Belg; 2009 Jun; (2):67-8. PubMed ID: 19739531
[No Abstract] [Full Text] [Related]
19. Evaluating obesity and cardiovascular risk factors in children and adolescents.
Spiotta RT; Luma GB
Am Fam Physician; 2008 Nov; 78(9):1052-8. PubMed ID: 19007051
[TBL] [Abstract][Full Text] [Related]
20. Obesity and cardiometabolic syndrome in children.
Velasquez-Mieyer P; Neira CP; Nieto R; Cowan PA
Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):61-81. PubMed ID: 19124396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
